Zobrazeno 1 - 5
of 5
pro vyhledávání: '"M Ram Vivek"'
Autor:
Anamika Singh Gaur, Lijo John, Nandan Kumar, M. Ram Vivek, Selvaraman Nagamani, Hridoy Jyoti Mahanta, G. Narahari Sastry
Publikováno v:
Molecular diversity.
A fragment-based drug discovery (FBDD) approach has traditionally been of utmost significance in drug design studies. It allows the exploration of large chemical space to find novel scaffolds and chemotypes which can be improved into selective inhibi
Publikováno v:
Journal of Chemical Sciences. 129:1053-1060
Many-body expansion (MBE) has been carried out to investigate two- to five-body energy terms and their contributions to the interaction energy (IE) of ( $$\hbox {H}_{2}\hbox {O})_{15}$$ cluster. We have observed that the erroneous contribution of man
Autor:
Subramanian Venkatesan, Neeraj Kumar Rajput, Pankaj Narang, Aparna Singh, Prasun Dutta, D Arun Kumar, Karunakar Tanneeru, Anurag Passi, Anshu Bhardwaj, Harish Jangra, Kaamini Raithatha, Uca Jaleel, Anamika Singh Gaur, Prasad V. Bharatam, G. Narahari Sastry, Anmol J. Hemrom, Ruchi Mishra, S Hemasri, Deepak R. Bharti, Gajendra Ps Raghava, Yogesh M. Joshi, Hari Sailaja, Rakesh Kumar, P Sri Saranya, Suresh Kumar, M Prasanthi, Deepak Pandit, Kumardeep Chaudhary, N Yedukondalu, M. Karthikeyan, R. Venkata Krishnan, Sridhara Janardhan, Devesh Kumar, M Ram Vivek, Neha Tripathi, E. R. Azhagiya Singam, Reetu Sharma, Asheesh Kumar, R Srinithi, Lijo John, Chinmayee Choudhury, Andrew M. Lynn, Arun Sharma, Abhaysinh Mori, Nandan Kumar, Vijay M. Khedkar, Charuvaka Muvva, Sandeep Singh, Chinmai Madhuri, Anirban Banerji
Publikováno v:
Journal of Chemical Sciences. 129:515-531
Molecular Property Diagnostic Suite ( $$\text {MPDS}^{\mathrm{TB}}$$ ) is a web tool ( http://mpds.osdd.net ) designed to assist the in silico drug discovery attempts towards Mycobacterium tuberculosis (Mtb). $$\text {MPDS}^{\mathrm{TB}}$$ tool has n
Publikováno v:
Molecular bioSystems. 12(11)
The emergence of drug resistant strains of Mycobacterium Tuberculosis (Mtb) accentuates the urgent need for the development of novel antitubercular drugs. The major causes of drug resistance are genetic mutations, the influx–efflux transporter syst
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.